CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 7 filers reported holding CHINA PHARMA HLDGS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $19,000 | +137.5% | 88,437 | +325.3% | 0.00% | +100.0% |
| Q1 2022 | $8,000 | -84.3% | 20,796 | -80.2% | 0.00% | -80.0% |
| Q4 2021 | $51,000 | +183.3% | 105,282 | +217.9% | 0.01% | +150.0% |
| Q3 2021 | $18,000 | -57.1% | 33,116 | -43.6% | 0.00% | -50.0% |
| Q2 2021 | $42,000 | +13.5% | 58,693 | +32.3% | 0.00% | +33.3% |
| Q1 2021 | $37,000 | +12.1% | 44,355 | -39.6% | 0.00% | -25.0% |
| Q4 2020 | $33,000 | +312.5% | 73,454 | +105.9% | 0.00% | +300.0% |
| Q4 2019 | $8,000 | -27.3% | 35,683 | -16.8% | 0.00% | 0.0% |
| Q3 2019 | $11,000 | +22.2% | 42,883 | +48.6% | 0.00% | 0.0% |
| Q2 2019 | $9,000 | -64.0% | 28,853 | -70.5% | 0.00% | 0.0% |
| Q4 2018 | $25,000 | +733.3% | 97,840 | +568.6% | 0.00% | – |
| Q2 2018 | $3,000 | -40.0% | 14,633 | -3.5% | 0.00% | – |
| Q1 2018 | $5,000 | -16.7% | 15,162 | -52.3% | 0.00% | – |
| Q4 2017 | $6,000 | -53.8% | 31,784 | -58.4% | 0.00% | -100.0% |
| Q3 2017 | $13,000 | – | 76,491 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| POPE ASSET MANAGEMENT, LLC | 2,104,826 | $632,000 | 0.51% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 1,290,463 | $387,000 | 0.07% |
| GLENHILL ADVISORS LLC | 200,000 | $60,000 | 0.01% |
| Renaissance Technologies | 136,300 | $41,000 | 0.00% |
| Virtu KCG Holdings LLC | 19,910 | $6,000 | 0.00% |
| UBS Group AG | 5,618 | $2,000 | 0.00% |